Clinuvel Pharmaceuticals Ltd
ASX:CUV
Dividends
Dividend Yield
Clinuvel Pharmaceuticals Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Clinuvel Pharmaceuticals Ltd
CUV have
increased
by 300%.
Payout Ratio
Clinuvel Pharmaceuticals Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for CUV is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CUV Price
Clinuvel Pharmaceuticals Ltd
| Average Annual Return | -9.65% |
| Standard Deviation of Annual Returns | 31.32% |
| Max Drawdown | -78% |
| Market Capitalization | 583.7m AUD |
| Shares Outstanding | 50 200 000 |
| Percentage of Shares Shorted |
N/A
|
CUV Return Decomposition
Main factors of price return
Stock Splits
CUV's latest stock split occurred on Nov 11, 2010
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
The adjusted shares began trading on Nov 11, 2010. This was CUV's 2nd stock split, following the previous one in Oct 5, 2006.
